Month: March 2018

Disability Claimants and the Implementation of a Web-Based Pain Assessment/Pain Management Program

How important is a pain management program in the clinical setting? Recently, Inflexxion partnered with Aetna Disability to answer this question, exploring the impact of using a clinical assessment system and pain management resources with disability claimants as part of a pain management program. Two of Inflexxion’s tools were implemented, PainCAS Clinical Assessment System, a… Read more »

Inflexxion is exhibiting at the American Society of Addiction Medication (ASAM) conference

Inflexxion is exhibiting at the American Society of Addiction Medicine conference at the Hilton San Diego Bayfront in San Diego, CA from April 12-15. Visit our booth, #607 to learn more about our behavioral health product suite.  This includes the Addiction Severity Index Multimedia Version (ASI-MV), our evidence-based, consumer self-administered assessment tool for behavioral health… Read more »

Webinar: Streamline the assessment process in your medication assisted treatment program

Click  here to register today! Join us on Thursday, March 29 at 1pm EST to learn how to streamline the assessment process in your medication assisted treatment program using the Addiction Severity Index Multimedia Version (ASI-MV) and Behavioral Health Index Multimedia Version (BHI-MV) evidence-based tools. These client self-administered behavioral health solutions gather data in a standardized… Read more »

Your questions about the COMM-9 answered

►What is the COMM-9? The COMM-9 is an evidence-based electronically administered clinical screening tool intended to identify and monitor aberrant opioid-related behavior in chronic pain patients on opioid therapy. It is a brief version of the Current Opioid Misuse Measure (COMM). The COMM and COMM-9 were developed with guidance from pain and addiction experts and… Read more »